GB1339210A - Venous injection for safety and effective plasma substitute including artificial starch and the preparation thereof - Google Patents
Venous injection for safety and effective plasma substitute including artificial starch and the preparation thereofInfo
- Publication number
- GB1339210A GB1339210A GB6049671A GB6049671A GB1339210A GB 1339210 A GB1339210 A GB 1339210A GB 6049671 A GB6049671 A GB 6049671A GB 6049671 A GB6049671 A GB 6049671A GB 1339210 A GB1339210 A GB 1339210A
- Authority
- GB
- United Kingdom
- Prior art keywords
- plasma substitute
- safety
- preparation
- effective plasma
- including artificial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
1339210 Plasma substitute KYORIN SEIYAKU KK 29 Dec 1971 [21 Aug 1971] 60496/ 71 Heading A5B A sterile, pyrogen free, aqueous solution containing 5.8-6.2% W/V of hydroxy ethyl starch having a degree of substitution of 0.5 to 0.6 and an intrinsic viscosity of 0.08 to 0.14, and containing sufficient inorganic and/or organic adjuvants (e.g. sodium, potassium and calcium salts, lactates and glucose) to ensure an ionic balance with blood and a pH of 6.2 Π0.5 may be used as a blood plasma substitute. It may be prepared by treating a solution of HES having the same degree of substitution but an intrinsic viscosity of 0.28 to 0.30 with an acid having a physiologically acceptable anion (e.g. HCl), adding appropriate adjuvants, sterilizing and removing pyrogens, e.g. by treatment with Raney nickel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6383871A JPS5439444B2 (en) | 1971-08-21 | 1971-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1339210A true GB1339210A (en) | 1973-11-28 |
Family
ID=13240875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB6049671A Expired GB1339210A (en) | 1971-08-21 | 1971-12-29 | Venous injection for safety and effective plasma substitute including artificial starch and the preparation thereof |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5439444B2 (en) |
| AU (1) | AU464057B2 (en) |
| BE (1) | BE778156A (en) |
| CA (1) | CA965006A (en) |
| DE (1) | DE2201669C3 (en) |
| ES (1) | ES402085A1 (en) |
| FR (1) | FR2150272B1 (en) |
| GB (1) | GB1339210A (en) |
| HU (1) | HU164073B (en) |
| MY (1) | MY7400261A (en) |
| ZA (1) | ZA728667B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE420565B (en) * | 1974-06-06 | 1981-10-19 | Pharmacia Ab | AID FOR INTRAVASCULAR ADMINISTRATION FOR USE IN CONNECTION WITH INTRAVASCULAR ADMINISTRATION OF A SOLUTION OR SUSPENSION OF A DIAGNOSTIC AGENT |
| DE3428201A1 (en) * | 1984-07-31 | 1986-02-06 | Laevosan-Gesellschaft mbH & Co. KG, Linz | PERITONEAL DIALYSIS SOLUTIONS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3523938A (en) * | 1967-12-13 | 1970-08-11 | American Hospital Supply Corp | Starch plasma expanders and process of preparation |
| GB1345976A (en) * | 1971-07-07 | 1974-02-06 | Bieganski Z | Stripping tools |
-
1971
- 1971-08-21 JP JP6383871A patent/JPS5439444B2/ja not_active Expired
- 1971-12-29 GB GB6049671A patent/GB1339210A/en not_active Expired
- 1971-12-30 CA CA131,469A patent/CA965006A/en not_active Expired
-
1972
- 1972-01-03 HU HUKI660A patent/HU164073B/hu unknown
- 1972-01-07 AU AU37712/72A patent/AU464057B2/en not_active Expired
- 1972-01-14 DE DE2201669A patent/DE2201669C3/en not_active Expired
- 1972-01-18 BE BE778156A patent/BE778156A/en not_active IP Right Cessation
- 1972-01-18 FR FR7201590A patent/FR2150272B1/fr not_active Expired
- 1972-02-02 ZA ZA728667*A patent/ZA728667B/en unknown
- 1972-04-25 ES ES402085A patent/ES402085A1/en not_active Expired
-
1974
- 1974-12-30 MY MY261/74A patent/MY7400261A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2150272A1 (en) | 1973-04-06 |
| DE2201669C3 (en) | 1981-05-07 |
| FR2150272B1 (en) | 1975-10-10 |
| DE2201669A1 (en) | 1973-02-22 |
| AU464057B2 (en) | 1975-08-14 |
| HU164073B (en) | 1973-12-28 |
| DE2201669B2 (en) | 1980-07-10 |
| ZA728667B (en) | 1973-05-30 |
| JPS5439444B2 (en) | 1979-11-28 |
| CA965006A (en) | 1975-03-25 |
| AU3771272A (en) | 1973-07-12 |
| MY7400261A (en) | 1974-12-31 |
| ES402085A1 (en) | 1975-03-01 |
| JPS4828618A (en) | 1973-04-16 |
| BE778156A (en) | 1972-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4700482A1 (en) | FORMULATIONS OF A MONOMER INSULIN ANALOG | |
| KR890011823A (en) | Benzoyl phenylacetic acid derivative pharmaceutical composition | |
| NO164419B (en) | WATER SOLUBLE CELLULOSEETS AND A PROCEDURE FOR PRODUCING THEREOF. | |
| KR920008026A (en) | Isoquinolinone derivatives or nontoxic acid addition salts thereof or hydrates thereof, methods for preparing the same, and pharmaceutical compositions comprising the same | |
| KR880003616A (en) | Wound healing | |
| KR870003786A (en) | Leaching solution of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl) -quinoline-3-carboxylic acid | |
| Shute | Latency and long-term relapses in benign tertian malaria | |
| KR920002172A (en) | Soluble Hemostatic Fabric | |
| US2575344A (en) | Dihydroxypropyl theophylline | |
| US3830824A (en) | Physiological organic acid silver allantoinates | |
| Meyer et al. | Relationship between “Spreading Factor” and Hyaluronidase. | |
| GB1339210A (en) | Venous injection for safety and effective plasma substitute including artificial starch and the preparation thereof | |
| GB1506327A (en) | Saline solution for oral administration and method of preparing the same | |
| KR970706844A (en) | A Storage Stable Water Solution for Infusion Containing A Thrombin Inhibitor | |
| GB2094142A (en) | Injectable solution containing theophylline and a basic amino acid | |
| GB1304595A (en) | ||
| Love et al. | Effect of pure natural and synthetic secretin on Brunner's gland secretion in dogs | |
| US2667440A (en) | Stabilized aqueous solutions of paraminosalicylic acid salts | |
| US2668135A (en) | Germ-counteracting compositions | |
| ES427653A1 (en) | 3-Hydroxyacyl aminomethyl-5-acylamino-2,4,6-triiodobenzoic acid salts as x-ray contrast agents | |
| US2684323A (en) | Procaine ascorbate preparation | |
| US3983232A (en) | Novel agent for treatment of dehydrations in veterinary medicine, process for preparation and new use thereof | |
| NO820701L (en) | PROCEDURE FOR THE PREPARATION OF 1- (1,3-BENZODIOKSOL-5-YL) -2-PYRROLIDINON. | |
| US3658963A (en) | Method of reducing intraocular pressure with a basic thymol ether | |
| CA1154676A (en) | Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |